Associations of in Utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men

Environmental Health Perspectives

Volumn 121, Issue 4, 2013, Pages 453-458

  Vested, Anne ^a   Ramlau Hansen, Cecilia Høst ^a,b   Olsen, Sjurdur Frodi ^c   Bonde, Jens Peter ^d   Kristensen, Susanne Lund ^a   Halldorsson, Thorhallur Ingi ^c,e   Becher, Georg ^f   Haug, Line Småstuen ^f   Ernst, Emil Hagen ^b   Toft, Gunnar ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF ICELAND   (Iceland)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

PFOA; PFOS; Prenatal exposure; Reproductive hormones; Semen quality

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

ADULT; ARTICLE; AZOOSPERMIA; BLOOD ANALYSIS; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SEMEN ANALYSIS; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TANDEM MASS SPECTROMETRY; TESTIS;

EID: 84875904060     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205118     Document Type: Article

References (39)

1. Appasamy M, Muttukrishna S, Pizzey AR, Ozturk O, Groome NP, Serhal P, et al. 2007. Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility. Reprod Biomed Online 14(2):159-165.
2. Bonde JP, Giwercman A, Ernst E. 1996. Identifying environmental risk to male reproductive function by occupational sperm studies: logistics and design options. Occup Environ Med 53:511-519.
3. Butenhoff JL, Kennedy GL Jr, Frame SR, O'Connor JC, York RG. 2004. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196(1-2):95-116.
4. de Kretser DM. 1979. Endocrinology of male infertility. Br Med Bull 35(2):187-192.
5. de Kretser DM, McLachlan RI, Robertson DM, Burger HG. 1989. Serum inhibin levels in normal men and men with testicular disorders. J Endocrinol 120(3):517-523.
6. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. 2006. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48(8):759-770.
7. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677-1682.
8. Giesy JP, Kannan K. 2001. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35(7):1339-1342.
9. Gordetsky J, van Wijngaarden E, O'Brien J. 2012. Redefining abnormal follicle-stimulating hormone in the male infertility population. BJU Int 110(4):568-572.
10. Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, et al. 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307(4):391-397.
11. Gützkow KB, Haug LS, Thomsen C, Sabaredzovic A, Becher G, Brunborg G. 2012. Placental transfer of perfluorinated compounds is selective-a Norwegian Mother and Child subCohort study. Int J Hyg Environ Health 215(2):216-219.
12. Haug LS, Huber S, Becher G, Thomsen C. 2011. Characterisation of human exposure pathways to perfluorinated compounds-comparing exposure estimates with biomarkers of exposure. Environ Int 37(4):687-693.
13. Haug LS, Thomsen C, Becher G. 2009. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J Chromatogr A 1216(3):385-393.
14. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204-1207.
15. Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sørensen HT, Bonde JP, et al. 2010. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology 21(6):779-785.
16. Joensen UN, Bossi R, Leffers H, Jensen AA, Skakkebaek NE, Jørgensen N. 2009. Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect 117:923-927.
17. Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, et al. 2004. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38(17):4489-4495.
18. Kissa E. 2001. Fluorinated Surfactants and Repellents. 2nd ed. New York:Marcel Dekker.
19. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99(2):366-394.
20. Menkveld R, Stander FS, Kotze TJ, Kruger TF, van Zyl JA. 1990. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 5(5):586-592.
21. Mocarelli P, Gerthoux PM, Needham LL, Patterson DG Jr, Limonta G, Falbo R, et al. 2011. Perinatal exposure to low doses of dioxin can permanently impair human semen quality. Environ Health Perspect 119:713-718.
22. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305.
23. Olsen GW, Lange CC, Ellefson ME, Mair DC, Church TR, Goldberg CL, et al. 2012. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environ Sci Technol 46(11):6330-6338.
24. Olsen SF, Hansen HS, Sandström B, Jensen B. 1995a. Erythrocyte levels compared with reported dietary intake of marine n-3 fatty acids in pregnant women. Br J Nutr 73(3):387-395.
25. Olsen SF, Hansen HS, Secher NJ, Jensen B, Sandström B. 1995b. Gestation length and birth weight in relation to intake of marine n-3 fatty acids. Br J Nutr 73(3):397-404.
26. Palmer JR, Herbst AL, Noller KL, Boggs DA, Troisi R, Titus-Ernstoff L, et al. 2009. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health 8:37; doi: 10.1186/1476-069X-8-37 [Online 18 August 2009].
27. Ramlau-Hansen CH, Thulstrup AM, Bonde JP, Ernst E. 2007. Is self-measuring of testicular volume by a Prader orchidometer a valid method? Fertil Steril 87(6):1480-1482.
28. Raymer JH, Michael LC, Studabaker WB, Olsen GW, Sloan CS, Wilcosky T, et al. 2012. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. Reprod Toxicol 33(4):419-427.
29. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. 2003. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125(6):769-784.
30. Shoeib M, Harner T, Webster GM, Lee SC. 2011. Indoor sources of polyand perfluorinated compounds (PFCS) in Vancouver, Canada: implications for human exposure. Environ Sci Technol 45:7999-8005.
31. Tittlemier SA, Pepper K, Edwards L. 2006. Concentrations of perfluorooctanesulfonamides in Canadian Total Diet Study composite food samples collected between 1992 and 2004. J Agric Food Chem 54(21):8385-8389.
32. Tittlemier SA, Pepper K, Seymour C, Moisey J, Bronson R, Cao XL et al. 2007. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 55(8):3203-3210.
33. Toft G, Jönsson BA, Lindh CH, Giwercman A, Spano M, Heederik D, et al. 2012. Exposure to perfluorinated compounds and human semen quality in Arctic and European populations. Hum Reprod 27(8):2532-2540.
34. Tüttelmann F, Dykstra N, Themmen AP, Visser JA, Nieschlag E, Simoni M. 2009. Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with mal descended testes. Fertil Steril 91(5):1812-1819.
35. Vested A, Ramlau-Hansen CH, Bonde JP, Thulstrup AM, Kristensen SL, Toft G. 2011. A comparison of conventional and computer-assisted semen analysis (CRISMAS software) using samples from 166 young Danish men. Asian J Androl 13(3):453-458.
36. Wan HT, Zhao YG, Wong MH, Lee KF, Yeung WS, Giesy JP, et al. 2011. Testicular signaling is the potential target of perfluorooctanesulfonate-mediated subfertility in male mice. Biol Reprod 84(5):1016-1023.
37. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, et al. 2008. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 118(4):1479-1490.
38. World Health Organization. 1999. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th ed. Cambridge, UK:Cambridge University Press.
39. York RG, Kennedy GL Jr, Olsen GW, Butenhoff JL. 2010. Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. Toxicology 271(1-2):64-72.